Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Statistics

Total Valuation

GYRE has a market cap or net worth of $742.02 million. The enterprise value is $692.68 million.

Market Cap	742.02M
Enterprise Value	692.68M

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

GYRE has 90.82 million shares outstanding. The number of shares has increased by 33.83% in one year.

Current Share Class	90.82M
Shares Outstanding	90.82M
Shares Change (YoY)	+33.83%
Shares Change (QoQ)	+0.72%
Owned by Insiders (%)	7.00%
Owned by Institutions (%)	3.58%
Float	20.46M

Valuation Ratios

The trailing PE ratio is 179.03.

PE Ratio	179.03
Forward PE	n/a
PS Ratio	6.95
Forward PS	7.06
PB Ratio	8.10
P/TBV Ratio	8.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	166.31
EV / Sales	6.78
EV / EBITDA	61.05
EV / EBIT	74.16
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.40, with a Debt / Equity ratio of 0.01.

Current Ratio	5.40
Quick Ratio	4.68
Debt / Equity	0.01
Debt / EBITDA	0.11
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.84% and return on invested capital (ROIC) is 5.16%.

Return on Equity (ROE)	7.84%
Return on Assets (ROA)	4.27%
Return on Invested Capital (ROIC)	5.16%
Return on Capital Employed (ROCE)	6.88%
Revenue Per Employee	$176,492
Profits Per Employee	$7,193
Employee Count	579
Asset Turnover	0.75
Inventory Turnover	0.58

Taxes

In the past 12 months, GYRE has paid $2.84 million in taxes.

Income Tax	2.84M
Effective Tax Rate	24.54%

Stock Price Statistics

The stock price has decreased by -23.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.06%
50-Day Moving Average	7.66
200-Day Moving Average	10.12
Relative Strength Index (RSI)	60.94
Average Volume (20 Days)	82,409

Short Selling Information

The latest short interest is 1.85 million, so 2.04% of the outstanding shares have been sold short.

Short Interest	1.85M
Short Previous Month	1.81M
Short % of Shares Out	2.04%
Short % of Float	9.05%
Short Ratio (days to cover)	19.51

Income Statement

In the last 12 months, GYRE had revenue of $102.19 million and earned $4.17 million in profits. Earnings per share was $0.02.

Revenue	102.19M
Gross Profit	98.01M
Operating Income	9.34M
Pretax Income	-74.61M
Net Income	4.17M
EBITDA	11.35M
EBIT	9.34M
Earnings Per Share (EPS)	$0.02

Balance Sheet

The company has $54.37 million in cash and $1.39 million in debt, giving a net cash position of $52.97 million or $0.58 per share.

Cash & Cash Equivalents	54.37M
Total Debt	1.39M
Net Cash	52.97M
Net Cash Per Share	$0.58
Equity (Book Value)	129.44M
Book Value Per Share	1.01
Working Capital	74.37M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 95.91%, with operating and profit margins of 9.14% and 4.08%.

Gross Margin	95.91%
Operating Margin	9.14%
Pretax Margin	11.33%
Profit Margin	4.08%
EBITDA Margin	11.10%
EBIT Margin	9.14%
FCF Margin	n/a

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.83%
Shareholder Yield	-33.83%
Earnings Yield	0.56%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GYRE has an Altman Z-Score of 26.98 and a Piotroski F-Score of 3.

Altman Z-Score	26.98
Piotroski F-Score	3